These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34750098)

  • 1. Systematic Pan-Cancer Characterization of Nuclear Receptors Identifies Potential Cancer Biomarkers and Therapeutic Targets.
    Jiang J; Yuan J; Hu Z; Xu M; Zhang Y; Long M; Fan Y; Montone KT; Tanyi JL; Tavana O; Chan HM; Zhang L; Hu X
    Cancer Res; 2022 Jan; 82(1):46-59. PubMed ID: 34750098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-cancer analyses of human nuclear receptors reveal transcriptome diversity and prognostic value across cancer types.
    Parris TZ
    Sci Rep; 2020 Feb; 10(1):1873. PubMed ID: 32024906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer.
    Jeong Y; Xie Y; Xiao G; Behrens C; Girard L; Wistuba II; Minna JD; Mangelsdorf DJ
    PLoS Med; 2010 Dec; 7(12):e1000378. PubMed ID: 21179495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer.
    Wang Z; Wu D; Ng CF; Teoh JY; Yu S; Wang Y; Chan FL
    Endocr Relat Cancer; 2018 Jan; 25(1):35-50. PubMed ID: 29042395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancer.
    Jeong Y; Xie Y; Lee W; Bookout AL; Girard L; Raso G; Behrens C; Wistuba II; Gadzar AF; Minna JD; Mangelsdorf DJ
    Mol Endocrinol; 2012 Aug; 26(8):1443-54. PubMed ID: 22700587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatment.
    Hu Z; Zhou J; Jiang J; Yuan J; Zhang Y; Wei X; Loo N; Wang Y; Pan Y; Zhang T; Zhong X; Long M; Montone KT; Tanyi JL; Fan Y; Wang TL; Shih IM; Hu X; Zhang L
    Nat Commun; 2019 Feb; 10(1):733. PubMed ID: 30760718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative omics analyses broaden treatment targets in human cancer.
    Sengupta S; Sun SQ; Huang KL; Oh C; Bailey MH; Varghese R; Wyczalkowski MA; Ning J; Tripathi P; McMichael JF; Johnson KJ; Kandoth C; Welch J; Ma C; Wendl MC; Payne SH; Fenyö D; Townsend RR; Dipersio JF; Chen F; Ding L
    Genome Med; 2018 Jul; 10(1):60. PubMed ID: 30053901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct nuclear receptor expression in stroma adjacent to breast tumors.
    Knower KC; Chand AL; Eriksson N; Takagi K; Miki Y; Sasano H; Visvader JE; Lindeman GJ; Funder JW; Fuller PJ; Simpson ER; Tilley WD; Leedman PJ; Graham J; Muscat GE; Clarke CL; Clyne CD
    Breast Cancer Res Treat; 2013 Nov; 142(1):211-23. PubMed ID: 24122391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear receptors in cancer - uncovering new and evolving roles through genomic analysis.
    Dhiman VK; Bolt MJ; White KP
    Nat Rev Genet; 2018 Mar; 19(3):160-174. PubMed ID: 29279606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Transcriptional Targets Regulated by Nuclear Receptors Using a Probabilistic Graphical Model.
    Lee M; Huang R; Tong W
    Toxicol Sci; 2016 Mar; 150(1):64-73. PubMed ID: 26643261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Accord of Nuclear Receptor Expression in CD4
    Saini A; Mahajan S; Bhagyaraj E; Kalra R; Nanduri R; Gupta R; Khatri N; Gupta P
    Immunohorizons; 2019 Aug; 3(8):402-411. PubMed ID: 31439624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis.
    Han SJ; O'Malley BW
    Hum Reprod Update; 2014; 20(4):467-84. PubMed ID: 24634322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors.
    Dienstmann R; Jang IS; Bot B; Friend S; Guinney J
    Cancer Discov; 2015 Feb; 5(2):118-23. PubMed ID: 25656898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Machine Learning Methods in Predicting Nuclear Receptors and their Families.
    Zhang ZM; Guan ZX; Wang F; Zhang D; Ding H
    Med Chem; 2020; 16(5):594-604. PubMed ID: 31584374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine nuclear receptors and long non‑coding RNAs reciprocal regulation in cancer (Review).
    Cantile M; Cerrone M; Di Bonito M; Moccia P; Tracey M; Ferrara G; Budillon A
    Int J Oncol; 2024 Jan; 64(1):. PubMed ID: 38038050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agreement between two large pan-cancer CRISPR-Cas9 gene dependency data sets.
    Dempster JM; Pacini C; Pantel S; Behan FM; Green T; Krill-Burger J; Beaver CM; Younger ST; Zhivich V; Najgebauer H; Allen F; Gonçalves E; Shepherd R; Doench JG; Yusa K; Vazquez F; Parts L; Boehm JS; Golub TR; Hahn WC; Root DE; Garnett MJ; Tsherniak A; Iorio F
    Nat Commun; 2019 Dec; 10(1):5817. PubMed ID: 31862961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions.
    Holbeck S; Chang J; Best AM; Bookout AL; Mangelsdorf DJ; Martinez ED
    Mol Endocrinol; 2010 Jun; 24(6):1287-96. PubMed ID: 20375240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
    Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
    Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
    Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using circulating cell-free DNA to monitor personalized cancer therapy.
    Oellerich M; Schütz E; Beck J; Kanzow P; Plowman PN; Weiss GJ; Walson PD
    Crit Rev Clin Lab Sci; 2017 May; 54(3):205-218. PubMed ID: 28393575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.